(Global confernce on news in melanoma/skin cancer)
Friday, June 27th 2014
Session- New drugs and trials: An update on immunotherapy and chemotherapy
9:36- Electroporation (Adil I. Daud)
In addition Punit Dhillion will be in attendance.
Gold sponsors for conference
Merck, Bristol Myers, GSK, Roche
Amgen, Celgene, Delcath, Medac, OncoSec
The interactive congress offers a comprehensive overview on all new developments in skin cancer and in particular melanoma therapy and a direct communication with the world´s leading experts in these fields. After being held as a joint meeting with the 8th World Congress on Melanoma and the 10th EADO annual conference 2013 in Hamburg, the congress will return to its origins in Munich in June 2014.
Presently there is an exciting time for the development of new drugs for skin cancer / melanoma treatments. New immunotherapies, selective kinase inhibitors, new vaccines, and other innovative strategies for the intratumoral and systemic use are under development and are approaching the market for melanoma rapidly. Some have already been approved in the recent years. Non-melanoma skin cancer has become an exciting arena for clinical research as well. Several new drugs as hedgehog inhibitors for basal cell carcinomas are currently used in the routine and in innovative trials.
However, it will be the main target for all of us to choose the right patients for the right drugs! The aim of the Interdisciplinary Global Conference on Developing New Treatments for Melanoma / Skin Cancer in Munich is to grant a deep overall insight into the development of new drugs for melanoma and other cutaneous malignancies. The lively interaction of clinicians, as well as experts in translational and basic research, and representatives of the pharmaceutical industry, guarantees a successful outcome for every participant.
International key opinion leaders on melanoma, non-melanoma skin cancer and cutaneous lymphomas will be invited to give an overview throughout specified presentations, to present latest clinical trial results, and to discuss on exciting new drugs with the audience. In addition to the scientific value of this meeting, every participant may seize the given opportunity to interact with experts in a familiar setting in one of the most interesting cities of Germany. Link-http://www.melanomaglobal2014.org/